Documents P-selectin may reduce myocardial damage during PCI in non-STEMI patients

1. The SELECT-ACS Trial Effects of the P-selectin antagonist inclacumab on myocardial damage after PCI for NSTEMI Jean-Claude Tardif MD Montreal Heart Institute University…

Documents Www.clinicaltrials.gov Identifier: NCT00699998 Gurbel PA, Erlinge D, Ohman EM, Jakubowski JA,...

www.clinicaltrials.gov Identifier: NCT00699998 Gurbel PA, Erlinge D, Ohman EM, Jakubowski JA, Goodman SG, Huber K, Chan MY, Cornel JH, White HD, Fox KAA, Prabhakaran D, Armstrong…